Recent Updates
Recently added Catalysts
BNBX Positive Sentiment Score: 70/100

Applied DNA Sciences to Begin Trading Under New Ticker 'BNBX' Reflecting Digital Asset Treasury Strategy Ticker changing from 'APDN' to 'BNBX' effective

Key Takeaway: Applied DNA Sciences, Inc. announced the change of its ticker symbol from 'APDN' to 'BNBX', effective October 7, 2025. This change reflects the company's commitment to a digital asset treasury strategy focused on yield generation and token accumulation within the Binance ecosystem. The company aims to enhance capital efficiency through innovative decentralized finance protocols. However, the plan carries inherent risks, including the volatility of BNB prices and uncertainties surrounding the untested yield strategies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Ticker change to 'BNBX' signifies strategic growth and adaptation.
  • Focus on digital asset treasury strategy may enhance capital efficiency.
  • Plans to implement innovative decentralized finance protocols.

CONCERNS & RISKS

  • Risks associated with the highly volatile nature of BNB prices.
  • The new yield generation strategy is unproven and carries uncertainties.
  • Potential regulatory uncertainties concerning digital assets could impact performance.

Full Press Release Details

DNA Sciences to Begin Trading Under New Ticker 'BNBX' Reflecting Digital Asset Treasury Strategy
changing from 'APDN' to 'BNBX' effective October 7, 2025
BROOK, N.Y. - Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a biotechnology
company advancing a yield focused BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced
that it will change its ticker symbol on the Nasdaq Capital Market ("Nasdaq") from "APDN" to "BNBX",
effective at the opening of trading on Tuesday October 7, 2025.
ticker BNBX underscores the Company's strategic commitment to a BNB-based treasury strategy designed to optimize yield generation and
token accumulation within the Binance ecosystem. The Company plans to implement a differentiated approach to treasury management, including
through the integration of actively managed decentralized finance protocols and Binance ecosystem specific strategies, aimed at enhancing
capital efficiency, liquidity resilience, and exposure to digital asset upside.
action by the Company's stockholders is required with respect to the ticker symbol change. The Company's common stock will continue to
be listed on Nasdaq and the CUSIP number will remain unchanged.
Applied DNA Sciences
DNA Sciences is a biotechnology company executing a yield focused BNB digital asset treasury strategy, while also commercializing proprietary
nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the
use of words such as "anticipate," "expect," "plan," "could," "may,"
"will," "believe," "estimate," "forecast," "goal," "project," and
other words of similar meaning. Forward-looking statements are statements other than historical facts and address various matters
including, without limitation, statements relating to the assets to be held by the Company, the expected future market, price and
liquidity of the digital assets the Company acquires, the macro and political conditions surrounding digital assets, the Company's
plan for value creation and strategic advantages, market size, market position, and growth opportunities, regulatory conditions,
competitive position and the interest of other corporations in similar business strategies, technological and market trends, future
announcements and priorities, expectations regarding management, future financial and operating condition and performance, the
expected financial impacts of the proposed transactions described herein and other projections or statements of plans and
forward-looking statements are based on current expectations, estimates, assumptions, and projections, and involve known and unknown
risks, uncertainties, and other factors-many of which are beyond the Company's control-that may cause actual results, performance,
or achievements to differ materially from those expressed or implied by such statements. Each forward-looking statement contained in
this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed
or implied by such statement. Applicable risks and uncertainties include, among others, failure to realize the anticipated benefits
of the proposed digital asset treasury strategy; changes in business, market, financial, political and regulatory conditions; risks
relating to the Company's operations and business, including the highly volatile nature of the price of BNB and other
cryptocurrencies; risks related to the Company's ability to raise and deploy capital effectively; risks relating to an unproven
yield generation strategy, the risk that the price of the Company's common stock may be highly correlated to the price of the
digital assets that it holds; risks related to increased competition in the industries in which the Company does and will operate;
risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; risks
relating to the treatment of crypto assets for U.S. and foreign tax purposes; risks related to the unknown returns, liquidity and/or
token accumulation that the Company's BNB treasury strategy will generate; risks relating to market volatility, cybersecurity and
custody of digital assets, potential changes in laws or accounting standards relating to cryptocurrency, and regulatory developments
affecting BNB or other digital assets; as well as those risks and uncertainties identified in the Company's filings with the
Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date of this document,
and the Company undertakes no obligation to update or revise any of these statements.
Relations: John Ragozzino Jr., CFA BnB@icrinc.com

Frequently Asked Questions

What is the new ticker symbol for Applied DNA Sciences?

The new ticker symbol is 'BNBX', effective October 7, 2025.

What strategy is Applied DNA Sciences focusing on?

The company is advancing a yield-focused BNB digital asset treasury strategy.

Will shareholder action be required for the ticker change?

No action by the Company's stockholders is required for the ticker symbol change.

Will Applied DNA's stock still be listed on Nasdaq?

Yes, the common stock will continue to be listed on Nasdaq.

What does the BNB treasury strategy aim to enhance?

It aims to enhance capital efficiency, liquidity resilience, and digital asset exposure.

Last updated: Oct 7, 2025